Interferon-gamma and the induction of protective IgG2a antibodies in non-lethal Plasmodium berghei infections of mice

Parasite Immunology
Seiji WakiM Suzuki

Abstract

Mice treated with anti-IFN-gamma monoclonal antibodies were unable to recover from infection with an attenuated variant of P. berghei (Pb XAT) which causes non-lethal malaria in normal mice. On the other hand, treatment with anti-IL-4 monoclonal antibodies had no effect on the course of infection. IFN-gamma was produced by spleen cells in vitro during the early phase of the infection. Treatment with anti-IFN-gamma suppressed development of an anti-plasmodial IgG2a immunoglobulin isotype in the serum of infected mice whereas anti-IL-4 interfered with the IgG1 response. An IgG2a fraction of immune serum collected from mice that had recovered from Pb XAT transferred immunity to naive mice but the IgG1 fraction did not. When glutaraldehyde fixed parasitized erythrocytes were incubated with immune serum in suspension, specific IgG2a antibodies were detected by fluorescein staining on the membranes of cells infected with mature stages of parasites. These results indicate that IFN-gamma is a key to inducing B cells to produce the protective antiplasmodial IgG2a immunoglobulin isotype. Antibody-dependent cell-mediated parasite killing seems to be involved in the mechanism of recovery from infection with Pb XAT.

References

Nov 1, 1990·Infection and Immunity·S J MedingJ Langhorne
Jan 1, 1991·Infection·J E Fowler
Jan 1, 1981·The Journal of School Health·A J Brennan
Feb 1, 1983·The Journal of Experimental Medicine·R A EzekowitzS Gordon
Oct 1, 1994·European Journal of Immunology·T von der WeidJ Langhorne

❮ Previous
Next ❯

Citations

Jun 1, 1997·Immunology and Cell Biology·N C SmithM F Good
May 23, 1998·Annual Review of Immunology·M F GoodL H Miller
Mar 20, 2010·Journal of Biomedicine & Biotechnology·Martha Legorreta-HerreraLeticia Moreno-Fierros
Jan 29, 2000·Parasite Immunology·D ChenG W Hutchinson
Jun 17, 2004·Parasite Immunology·M Legorreta-HerreraF F Hernández-Clemente
May 18, 1999·Experimental Parasitology·L Favila-CastilloD Garcia-Tapia
Feb 2, 2000·International Immunology·D Markine-GoriaynoffJ P Coutelier
Nov 6, 2013·Parasite Immunology·J B de Souza
Feb 23, 2007·Clinical and Vaccine Immunology : CVI·Pimmada JeamwattanalertChakrit Hirunpetcharat
Aug 20, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Fiona H AmanteChristian R Engwerda
Jan 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zhong Su, Mary M Stevenson
May 9, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·T YonetoT Yoshimoto
Aug 6, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Takayuki YoshimotoJunichiro Mizuguchi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.